ABVX
Abivax S.A.
91.10$
-4.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 23 | Q2 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +101.2% | +14.9% | -44.2% | +73.0% | -32.9% | +11.4% | +0.0% | -8.1% | +8.4% | +85.9% | -27.4% | – | |
| – | – | – | – | -1.5% | -23.3% | +7.9% | +0.0% | +35.0% | +81.2% | -196.0% | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -67.4% | -532.7% | – | -12.4% | +0.0% | -28.4% | -132.2% | – | -507.5% | – | |
| – | +101.4% | -21.5% | -89.7% | +1,791.7% | +37.0% | -85.9% | +0.0% | -56.8% | -100.0% | – | +575.0% | – | |
| – | +100.0% | +413.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | -8.7% | -114.3% | -23.1% | +173.1% | +12.9% | -17.0% | +610.8% | -99.0% | – | |
| – | +102.1% | +88.6% | -90.5% | -9.8% | -132.9% | +24.6% | +0.0% | +11.9% | – | +0.0% | -100.0% | – | |
| – | +100.0% | +57.3% | -107.5% | – | – | – | – | – | – | +0.0% | -107.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.